Sign up today for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!

Zynerba Higher Despite Q3 Miss

Courtesy of Benzinga.

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) shares are trading higher by $1.07 at $13.18 in Tuesday’s session. Despite a Q3 EPS miss of 4 cents, the stock is trading in the green.

After a lower open, Zynerba immediately found support at $11.40 and began to move higher. That low coincides with Friday’s low of $11.30. As of 3:06 p.m. EST, the ensuing rally found resistance just above Monday’s high ($13.66), reaching $13.74. In order to fill the void price from its August 4 session, it will need to reach $13.83.

On the following day, the stock swooned to $6.67 from its $15.06 close following a disappointing Phase 2 trial of ZYN002 for treatment of adult epileptic patients with focal seizures.

Posted-In: Technicals Intraday Update Movers Trading Ideas


Do you know someone who would benefit from this information? We can send your friend a strictly confidential, one-time email telling them about this information. Your privacy and your friend's privacy is your business... no spam! Click here and tell a friend!





You must be logged in to make a comment.
You can sign up for a membership or get a FREE Daily News membership or log in

Sign up today for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!